401k Plan data: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN plan

THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 401k Plan overview

Plan Name	THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN
Plan identification number	002

THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.

401k Sponsoring company profile

THE UNITED STATES PHARMACOPEIAL CONVENTION has sponsored the creation of one or more 401k plans.

Company Name: THE UNITED STATES PHARMACOPEIAL CONVENTION

Employer identification number (EIN): 131656692

NAIC Classification: 611000

Form 5500 Filing Information

Submission information for form 5500 for 401k plan THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
002 2022-01-01
002 2021-01-01
002 2020-01-01
002 2019-01-01
002 2018-01-01
002 2017-01-01 CHRISTINE STUNYO KENNETH ALEXANDER 2018-09-20
002 2016-01-01 CHRISTINE STUNYO KENNETH ALEXANDER 2017-10-10
002 2015-01-01 CHRISTINE STUNYO KENNETH ALEXANDER 2016-10-06
002 2014-01-01 JAMES THOMPSON KENNETH ALEXANDER 2015-10-12
002 2013-01-01 SUSAN BACH JAMES THOMPSON 2014-07-31
002 2012-01-01 SUSAN BACH JAMES THOMPSON 2013-10-03
002 2011-01-01 SUSAN BACH JAMES P. THOMPSON 2013-09-05

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
002	2022-01-01
002	2021-01-01
002	2020-01-01
002	2019-01-01
002	2018-01-01
002	2017-01-01	CHRISTINE STUNYO	KENNETH ALEXANDER	2018-09-20
002	2016-01-01	CHRISTINE STUNYO	KENNETH ALEXANDER	2017-10-10
002	2015-01-01	CHRISTINE STUNYO	KENNETH ALEXANDER	2016-10-06
002	2014-01-01	JAMES THOMPSON	KENNETH ALEXANDER	2015-10-12
002	2013-01-01	SUSAN BACH	JAMES THOMPSON	2014-07-31
002	2012-01-01	SUSAN BACH	JAMES THOMPSON	2013-10-03
002	2011-01-01	SUSAN BACH	JAMES P. THOMPSON	2013-09-05

Plan Statistics for THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN

401k plan membership statisitcs for THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN

Measure Date Value
2022: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 1,073
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 837
Number of retired or separated participants receiving benefits 2022-01-01 8
Number of other retired or separated participants entitled to future benefits 2022-01-01 279
Total of all active and inactive participants 2022-01-01 1,124
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 3
Total participants 2022-01-01 1,127
Number of participants with account balances 2022-01-01 1,110
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 1,061
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 795
Number of retired or separated participants receiving benefits 2021-01-01 7
Number of other retired or separated participants entitled to future benefits 2021-01-01 266
Total of all active and inactive participants 2021-01-01 1,068
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 5
Total participants 2021-01-01 1,073
Number of participants with account balances 2021-01-01 1,061
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 1,063
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 801
Number of retired or separated participants receiving benefits 2020-01-01 1
Number of other retired or separated participants entitled to future benefits 2020-01-01 255
Total of all active and inactive participants 2020-01-01 1,057
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 4
Total participants 2020-01-01 1,061
Number of participants with account balances 2020-01-01 1,053
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 991
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 852
Number of retired or separated participants receiving benefits 2019-01-01 10
Number of other retired or separated participants entitled to future benefits 2019-01-01 197
Total of all active and inactive participants 2019-01-01 1,059
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 4
Total participants 2019-01-01 1,063
Number of participants with account balances 2019-01-01 1,056
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 953
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 822
Number of retired or separated participants receiving benefits 2018-01-01 9
Number of other retired or separated participants entitled to future benefits 2018-01-01 157
Total of all active and inactive participants 2018-01-01 988
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 3
Total participants 2018-01-01 991
Number of participants with account balances 2018-01-01 979
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 924
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 0
Number of retired or separated participants receiving benefits 2017-01-01 7
Number of other retired or separated participants entitled to future benefits 2017-01-01 932
Total of all active and inactive participants 2017-01-01 939
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 7
Total participants 2017-01-01 946
Number of participants with account balances 2017-01-01 946
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 822
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 757
Number of retired or separated participants receiving benefits 2016-01-01 4
Number of other retired or separated participants entitled to future benefits 2016-01-01 158
Total of all active and inactive participants 2016-01-01 919
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 5
Total participants 2016-01-01 924
Number of participants with account balances 2016-01-01 924
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 754
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 679
Number of retired or separated participants receiving benefits 2015-01-01 4
Number of other retired or separated participants entitled to future benefits 2015-01-01 135
Total of all active and inactive participants 2015-01-01 818
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 4
Total participants 2015-01-01 822
Number of participants with account balances 2015-01-01 816
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 721
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 635
Number of retired or separated participants receiving benefits 2014-01-01 3
Number of other retired or separated participants entitled to future benefits 2014-01-01 104
Total of all active and inactive participants 2014-01-01 742
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 2
Total participants 2014-01-01 744
Number of participants with account balances 2014-01-01 754
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0
2013: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 651
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 627
Number of retired or separated participants receiving benefits 2013-01-01 1
Number of other retired or separated participants entitled to future benefits 2013-01-01 90
Total of all active and inactive participants 2013-01-01 718
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 3
Total participants 2013-01-01 721
Number of participants with account balances 2013-01-01 719
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 0
2012: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 578
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 576
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 73
Total of all active and inactive participants 2012-01-01 649
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 2
Total participants 2012-01-01 651
Number of participants with account balances 2012-01-01 624
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 0
2011: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 522
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 530
Number of retired or separated participants receiving benefits 2011-01-01 0
Number of other retired or separated participants entitled to future benefits 2011-01-01 47
Total of all active and inactive participants 2011-01-01 577
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 1
Total participants 2011-01-01 578
Number of participants with account balances 2011-01-01 537
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 0

Measure	Date	Value
2022: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	1,073
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	837
Number of retired or separated participants receiving benefits	2022-01-01	8
Number of other retired or separated participants entitled to future benefits	2022-01-01	279
Total of all active and inactive participants	2022-01-01	1,124
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	3
Total participants	2022-01-01	1,127
Number of participants with account balances	2022-01-01	1,110
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	1,061
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	795
Number of retired or separated participants receiving benefits	2021-01-01	7
Number of other retired or separated participants entitled to future benefits	2021-01-01	266
Total of all active and inactive participants	2021-01-01	1,068
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	5
Total participants	2021-01-01	1,073
Number of participants with account balances	2021-01-01	1,061
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	1,063
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	801
Number of retired or separated participants receiving benefits	2020-01-01	1
Number of other retired or separated participants entitled to future benefits	2020-01-01	255
Total of all active and inactive participants	2020-01-01	1,057
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	4
Total participants	2020-01-01	1,061
Number of participants with account balances	2020-01-01	1,053
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	991
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	852
Number of retired or separated participants receiving benefits	2019-01-01	10
Number of other retired or separated participants entitled to future benefits	2019-01-01	197
Total of all active and inactive participants	2019-01-01	1,059
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	4
Total participants	2019-01-01	1,063
Number of participants with account balances	2019-01-01	1,056
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	953
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	822
Number of retired or separated participants receiving benefits	2018-01-01	9
Number of other retired or separated participants entitled to future benefits	2018-01-01	157
Total of all active and inactive participants	2018-01-01	988
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	3
Total participants	2018-01-01	991
Number of participants with account balances	2018-01-01	979
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	924
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	0
Number of retired or separated participants receiving benefits	2017-01-01	7
Number of other retired or separated participants entitled to future benefits	2017-01-01	932
Total of all active and inactive participants	2017-01-01	939
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	7
Total participants	2017-01-01	946
Number of participants with account balances	2017-01-01	946
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	822
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	757
Number of retired or separated participants receiving benefits	2016-01-01	4
Number of other retired or separated participants entitled to future benefits	2016-01-01	158
Total of all active and inactive participants	2016-01-01	919
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	5
Total participants	2016-01-01	924
Number of participants with account balances	2016-01-01	924
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	754
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	679
Number of retired or separated participants receiving benefits	2015-01-01	4
Number of other retired or separated participants entitled to future benefits	2015-01-01	135
Total of all active and inactive participants	2015-01-01	818
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	4
Total participants	2015-01-01	822
Number of participants with account balances	2015-01-01	816
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	721
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	635
Number of retired or separated participants receiving benefits	2014-01-01	3
Number of other retired or separated participants entitled to future benefits	2014-01-01	104
Total of all active and inactive participants	2014-01-01	742
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	2
Total participants	2014-01-01	744
Number of participants with account balances	2014-01-01	754
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0
2013: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	651
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	627
Number of retired or separated participants receiving benefits	2013-01-01	1
Number of other retired or separated participants entitled to future benefits	2013-01-01	90
Total of all active and inactive participants	2013-01-01	718
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	3
Total participants	2013-01-01	721
Number of participants with account balances	2013-01-01	719
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	0
2012: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	578
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	576
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	73
Total of all active and inactive participants	2012-01-01	649
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	2
Total participants	2012-01-01	651
Number of participants with account balances	2012-01-01	624
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	0
2011: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	522
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	530
Number of retired or separated participants receiving benefits	2011-01-01	0
Number of other retired or separated participants entitled to future benefits	2011-01-01	47
Total of all active and inactive participants	2011-01-01	577
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	1
Total participants	2011-01-01	578
Number of participants with account balances	2011-01-01	537
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	0

Financial Data on THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN

Measure	Date	Value
2022 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2022 401k financial data
Total transfer of assets to this plan	2022-12-31	$2,681
Total income from all sources (including contributions)	2022-12-31	$-20,794,604
Total of all expenses incurred	2022-12-31	$13,774,510
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$13,607,973
Value of total corrective distributions	2022-12-31	$1,143
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$22,231,206
Value of total assets at end of year	2022-12-31	$242,729,243
Value of total assets at beginning of year	2022-12-31	$277,295,676
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$165,394
Total interest from all sources	2022-12-31	$64,081
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$4,807,423
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$4,807,423
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$10,148,301
Participant contributions at end of year	2022-12-31	$1,408,079
Participant contributions at beginning of year	2022-12-31	$1,270,840
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$1,119,091
Value of other receiveables (less allowance for doubtful accounts) at end of year	2022-12-31	$1,998
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2022-12-31	$1,502
Administrative expenses (other) incurred	2022-12-31	$165,394
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-34,569,114
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$242,729,243
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$277,295,676
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$205,432,733
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$231,482,583
Interest on participant loans	2022-12-31	$63,849
Interest earned on other investments	2022-12-31	$232
Value of interest in common/collective trusts at end of year	2022-12-31	$35,854,734
Value of interest in common/collective trusts at beginning of year	2022-12-31	$44,540,122
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$31,699
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$629
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-38,768,570
Net investment gain or loss from common/collective trusts	2022-12-31	$-9,128,744
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$10,963,814
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$13,607,973
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2022-12-31	No
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	APRIO LLP
Accountancy firm EIN	2022-12-31	571157523
2021 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2021 401k financial data
Total transfer of assets to this plan	2021-12-31	$5,793
Total income from all sources (including contributions)	2021-12-31	$54,259,779
Total of all expenses incurred	2021-12-31	$16,696,459
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$16,492,365
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$21,138,066
Value of total assets at end of year	2021-12-31	$277,295,676
Value of total assets at beginning of year	2021-12-31	$239,726,563
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$204,094
Total interest from all sources	2021-12-31	$63,992
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$4,780,521
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$4,780,521
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$9,544,802
Participant contributions at end of year	2021-12-31	$1,270,840
Participant contributions at beginning of year	2021-12-31	$1,344,015
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$932,356
Value of other receiveables (less allowance for doubtful accounts) at end of year	2021-12-31	$1,502
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2021-12-31	$1,559
Administrative expenses (other) incurred	2021-12-31	$204,094
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$37,563,320
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$277,295,676
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$239,726,563
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$231,482,583
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$219,528,950
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$0
Interest on participant loans	2021-12-31	$63,961
Interest earned on other investments	2021-12-31	$31
Value of interest in common/collective trusts at end of year	2021-12-31	$44,540,122
Value of interest in common/collective trusts at beginning of year	2021-12-31	$18,837,360
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$629
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$14,679
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$28,894,911
Net investment gain or loss from common/collective trusts	2021-12-31	$-617,711
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$10,660,908
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$16,492,365
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2021-12-31	No
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	ARONSON LLC
Accountancy firm EIN	2021-12-31	371611326
2020 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2020 401k financial data
Total transfer of assets to this plan	2020-12-31	$26,549
Total income from all sources (including contributions)	2020-12-31	$51,782,578
Total of all expenses incurred	2020-12-31	$14,720,754
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$14,542,307
Value of total corrective distributions	2020-12-31	$891
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$22,737,178
Value of total assets at end of year	2020-12-31	$239,726,563
Value of total assets at beginning of year	2020-12-31	$202,638,190
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$177,556
Total interest from all sources	2020-12-31	$72,273
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$3,501,154
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$3,501,154
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$9,509,539
Participant contributions at end of year	2020-12-31	$1,344,015
Participant contributions at beginning of year	2020-12-31	$1,346,388
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$2,462,694
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$1,559
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-12-31	$684
Administrative expenses (other) incurred	2020-12-31	$177,556
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$37,061,824
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$239,726,563
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$202,638,190
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$219,528,950
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$196,458,946
Value of interest in pooled separate accounts at end of year	2020-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$4,667,194
Interest on participant loans	2020-12-31	$71,647
Interest earned on other investments	2020-12-31	$626
Value of interest in common/collective trusts at end of year	2020-12-31	$18,837,360
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$14,679
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$164,978
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$24,387,496
Net investment gain/loss from pooled separate accounts	2020-12-31	$50,482
Net investment gain or loss from common/collective trusts	2020-12-31	$1,033,995
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$10,764,945
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$14,542,307
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2020-12-31	No
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	ARONSON LLC
Accountancy firm EIN	2020-12-31	371611326
2019 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2019 401k financial data
Total transfer of assets to this plan	2019-12-31	$278,455
Total income from all sources (including contributions)	2019-12-31	$55,527,662
Total of all expenses incurred	2019-12-31	$10,829,858
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$10,651,270
Value of total corrective distributions	2019-12-31	$4,069
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$21,292,221
Value of total assets at end of year	2019-12-31	$202,638,190
Value of total assets at beginning of year	2019-12-31	$157,661,931
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$174,519
Total interest from all sources	2019-12-31	$68,902
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$4,302,819
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$4,302,819
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$8,952,091
Participant contributions at end of year	2019-12-31	$1,346,388
Participant contributions at beginning of year	2019-12-31	$1,209,175
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$2,008,051
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$684
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$0
Administrative expenses (other) incurred	2019-12-31	$174,519
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$44,697,804
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$202,638,190
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$157,661,931
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$196,458,946
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$152,825,950
Value of interest in pooled separate accounts at end of year	2019-12-31	$4,667,194
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$3,463,462
Interest on participant loans	2019-12-31	$67,269
Interest earned on other investments	2019-12-31	$1,633
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$164,978
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$163,344
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$29,784,908
Net investment gain/loss from pooled separate accounts	2019-12-31	$78,812
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$10,332,079
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$10,651,270
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	No
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	ARONSON LLC
Accountancy firm EIN	2019-12-31	371611326
2018 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2018 401k financial data
Total transfer of assets to this plan	2018-12-31	$306,516
Total income from all sources (including contributions)	2018-12-31	$9,408,807
Total of all expenses incurred	2018-12-31	$8,820,957
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$8,633,509
Value of total corrective distributions	2018-12-31	$12,582
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$19,622,551
Value of total assets at end of year	2018-12-31	$157,661,931
Value of total assets at beginning of year	2018-12-31	$156,767,565
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$174,866
Total interest from all sources	2018-12-31	$58,191
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$4,075,163
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$4,075,163
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$8,380,727
Participant contributions at end of year	2018-12-31	$1,209,175
Participant contributions at beginning of year	2018-12-31	$1,041,907
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$1,005,143
Administrative expenses (other) incurred	2018-12-31	$174,866
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$587,850
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$157,661,931
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$156,767,565
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$152,825,950
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$152,514,633
Value of interest in pooled separate accounts at end of year	2018-12-31	$3,463,462
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$3,083,370
Interest on participant loans	2018-12-31	$56,760
Interest earned on other investments	2018-12-31	$1,431
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2018-12-31	$163,344
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2018-12-31	$127,655
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-14,389,814
Net investment gain/loss from pooled separate accounts	2018-12-31	$42,716
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$10,236,681
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$8,633,509
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	No
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	ARONSON LLC
Accountancy firm EIN	2018-12-31	371611326
2017 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2017 401k financial data
Total transfer of assets to this plan	2017-12-31	$288,741
Total income from all sources (including contributions)	2017-12-31	$40,629,630
Total of all expenses incurred	2017-12-31	$3,695,606
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$3,525,073
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$19,258,564
Value of total assets at end of year	2017-12-31	$156,767,565
Value of total assets at beginning of year	2017-12-31	$119,544,800
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$170,533
Total interest from all sources	2017-12-31	$38,865
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$3,395,716
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$3,395,716
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$7,854,355
Participant contributions at end of year	2017-12-31	$1,041,907
Participant contributions at beginning of year	2017-12-31	$678,494
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$2,239,896
Administrative expenses (other) incurred	2017-12-31	$170,533
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$36,934,024
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$156,767,565
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$119,544,800
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$152,514,633
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$115,725,080
Value of interest in pooled separate accounts at end of year	2017-12-31	$3,083,370
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$3,021,831
Interest on participant loans	2017-12-31	$37,671
Interest earned on other investments	2017-12-31	$1,194
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2017-12-31	$127,655
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2017-12-31	$119,395
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$17,903,263
Net investment gain/loss from pooled separate accounts	2017-12-31	$33,222
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$9,164,313
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$3,525,073
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2017-12-31	No
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	ARONSON LLC
Accountancy firm EIN	2017-12-31	371611326
2016 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2016 401k financial data
Total transfer of assets to this plan	2016-12-31	$313,927
Total income from all sources (including contributions)	2016-12-31	$26,303,736
Total of all expenses incurred	2016-12-31	$6,880,381
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$6,749,373
Value of total corrective distributions	2016-12-31	$2,995
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$17,867,762
Value of total assets at end of year	2016-12-31	$119,544,800
Value of total assets at beginning of year	2016-12-31	$99,807,518
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$128,013
Total interest from all sources	2016-12-31	$31,993
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$2,079,869
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$2,079,869
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$6,894,651
Participant contributions at end of year	2016-12-31	$678,494
Participant contributions at beginning of year	2016-12-31	$773,838
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$3,089,785
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2016-12-31	$117
Administrative expenses (other) incurred	2016-12-31	$128,013
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$19,423,355
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$119,544,800
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$99,807,518
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$115,725,080
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$96,778,163
Value of interest in pooled separate accounts at end of year	2016-12-31	$3,021,831
Value of interest in pooled separate accounts at beginning of year	2016-12-31	$2,249,050
Interest on participant loans	2016-12-31	$31,077
Interest earned on other investments	2016-12-31	$916
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2016-12-31	$119,395
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2016-12-31	$6,350
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$6,295,584
Net investment gain/loss from pooled separate accounts	2016-12-31	$28,528
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$7,883,326
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$6,749,373
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2016-12-31	No
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	ARONSON LLC
Accountancy firm EIN	2016-12-31	371611326
2015 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2015 401k financial data
Total transfer of assets to this plan	2015-12-31	$323,322
Total income from all sources (including contributions)	2015-12-31	$13,577,999
Total of all expenses incurred	2015-12-31	$5,239,304
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$5,100,053
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$15,140,610
Value of total assets at end of year	2015-12-31	$99,807,518
Value of total assets at beginning of year	2015-12-31	$91,145,501
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$139,251
Total interest from all sources	2015-12-31	$28,335
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$1,732,308
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$1,732,308
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$5,979,002
Participant contributions at end of year	2015-12-31	$773,838
Participant contributions at beginning of year	2015-12-31	$567,284
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$1,579,338
Value of other receiveables (less allowance for doubtful accounts) at end of year	2015-12-31	$117
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2015-12-31	$473
Administrative expenses (other) incurred	2015-12-31	$139,251
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$8,338,695
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$99,807,518
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$91,145,501
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$96,778,163
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$88,573,617
Value of interest in pooled separate accounts at end of year	2015-12-31	$2,249,050
Value of interest in pooled separate accounts at beginning of year	2015-12-31	$2,003,677
Interest on participant loans	2015-12-31	$28,287
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2015-12-31	$48
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2015-12-31	$6,350
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2015-12-31	$450
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-3,347,562
Net investment gain/loss from pooled separate accounts	2015-12-31	$24,308
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$7,582,270
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$5,100,053
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2015-12-31	No
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	ARONSON LLC
Accountancy firm EIN	2015-12-31	371611326
2014 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2014 401k financial data
Total transfer of assets to this plan	2014-12-31	$522,077
Total income from all sources (including contributions)	2014-12-31	$17,643,210
Total of all expenses incurred	2014-12-31	$4,378,227
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$4,260,461
Value of total corrective distributions	2014-12-31	$417
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$12,791,382
Value of total assets at end of year	2014-12-31	$91,145,501
Value of total assets at beginning of year	2014-12-31	$77,358,441
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$117,349
Total interest from all sources	2014-12-31	$20,402
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$1,626,412
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$1,626,412
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$5,398,230
Participant contributions at end of year	2014-12-31	$567,284
Participant contributions at beginning of year	2014-12-31	$390,688
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$551,104
Value of other receiveables (less allowance for doubtful accounts) at end of year	2014-12-31	$473
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2014-12-31	$163
Administrative expenses (other) incurred	2014-12-31	$117,349
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$13,264,983
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$91,145,501
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$77,358,441
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$88,573,617
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$75,140,598
Value of interest in pooled separate accounts at end of year	2014-12-31	$2,003,677
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$1,826,547
Interest on participant loans	2014-12-31	$20,398
Interest earned on other investments	2014-12-31	$4
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2014-12-31	$450
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2014-12-31	$445
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$3,192,367
Net investment gain/loss from pooled separate accounts	2014-12-31	$12,647
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$6,842,048
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$4,260,461
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2014-12-31	No
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	ARONSON LLC
Accountancy firm EIN	2014-12-31	371611326
2013 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2013 401k financial data
Total transfer of assets to this plan	2013-12-31	$342,030
Total income from all sources (including contributions)	2013-12-31	$23,232,991
Total of all expenses incurred	2013-12-31	$2,771,415
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$2,681,052
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$12,420,026
Value of total assets at end of year	2013-12-31	$77,358,441
Value of total assets at beginning of year	2013-12-31	$56,554,835
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$90,363
Total interest from all sources	2013-12-31	$17,561
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$1,272,541
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$1,272,541
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$500,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$4,820,341
Participant contributions at end of year	2013-12-31	$390,688
Participant contributions at beginning of year	2013-12-31	$379,526
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$1,456,075
Value of other receiveables (less allowance for doubtful accounts) at end of year	2013-12-31	$163
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2013-12-31	$151
Administrative expenses (other) incurred	2013-12-31	$90,363
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$20,461,576
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$77,358,441
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$56,554,835
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$75,140,598
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$54,511,363
Value of interest in pooled separate accounts at end of year	2013-12-31	$1,826,547
Value of interest in pooled separate accounts at beginning of year	2013-12-31	$1,663,676
Interest on participant loans	2013-12-31	$17,557
Interest earned on other investments	2013-12-31	$4
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2013-12-31	$445
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2013-12-31	$119
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$9,547,082
Net investment gain/loss from pooled separate accounts	2013-12-31	$-24,219
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$6,143,610
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$2,681,052
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2013-12-31	No
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	ARONSON LLC
Accountancy firm EIN	2013-12-31	371611326
2012 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2012 401k financial data
Total transfer of assets to this plan	2012-12-31	$362,425
Total income from all sources (including contributions)	2012-12-31	$17,057,320
Total of all expenses incurred	2012-12-31	$1,381,369
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$1,380,094
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$10,872,795
Value of total assets at end of year	2012-12-31	$56,554,835
Value of total assets at beginning of year	2012-12-31	$40,516,459
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$1,275
Total interest from all sources	2012-12-31	$14,991
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$1,297,956
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$1,297,956
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$500,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$4,209,898
Participant contributions at end of year	2012-12-31	$379,526
Participant contributions at beginning of year	2012-12-31	$290,720
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$1,297,526
Value of other receiveables (less allowance for doubtful accounts) at end of year	2012-12-31	$151
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2012-12-31	$75
Administrative expenses (other) incurred	2012-12-31	$1,275
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$15,675,951
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$56,554,835
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$40,516,459
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$54,511,363
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$38,841,219
Value of interest in pooled separate accounts at end of year	2012-12-31	$1,663,676
Value of interest in pooled separate accounts at beginning of year	2012-12-31	$1,294,023
Interest on participant loans	2012-12-31	$14,991
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2012-12-31	$119
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2012-12-31	$20
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$4,824,986
Net investment gain/loss from pooled separate accounts	2012-12-31	$46,592
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$5,365,371
Employer contributions (assets) at beginning of year	2012-12-31	$90,402
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$1,380,094
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2012-12-31	No
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	ARONSON LLC
Accountancy firm EIN	2012-12-31	371611326
2011 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2011 401k financial data
Total transfer of assets to this plan	2011-12-31	$595,291
Total income from all sources (including contributions)	2011-12-31	$8,380,583
Total of all expenses incurred	2011-12-31	$824,457
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$823,033
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$9,210,149
Value of total assets at end of year	2011-12-31	$40,516,459
Value of total assets at beginning of year	2011-12-31	$32,365,042
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$1,424
Total interest from all sources	2011-12-31	$5,885
Total dividends received (eg from common stock, registered investment company shares)	2011-12-31	$887,855
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2011-12-31	$887,855
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$500,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$3,554,508
Participant contributions at end of year	2011-12-31	$290,720
Participant contributions at beginning of year	2011-12-31	$47,298
Income. Received or receivable in cash from other sources (including rollovers)	2011-12-31	$803,149
Value of other receiveables (less allowance for doubtful accounts) at end of year	2011-12-31	$75
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2011-12-31	$12
Assets. Loans (other than to participants) at end of year	2011-12-31	$290,720
Assets. Loans (other than to participants) at beginning of year	2011-12-31	$47,298
Administrative expenses (other) incurred	2011-12-31	$1,424
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$7,556,126
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$40,516,459
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$32,365,042
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$38,841,219
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$31,357,585
Value of interest in pooled separate accounts at end of year	2011-12-31	$1,294,023
Value of interest in pooled separate accounts at beginning of year	2011-12-31	$960,127
Interest on participant loans	2011-12-31	$5,885
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2011-12-31	$20
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2011-12-31	$20
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-1,776,942
Net investment gain/loss from pooled separate accounts	2011-12-31	$53,636
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$4,852,492
Employer contributions (assets) at end of year	2011-12-31	$90,402
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$823,033
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2011-12-31	No
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	GRANT THORNTON LLP
Accountancy firm EIN	2011-12-31	366055558
2010 : THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets	2010-12-31	$0
Total transfer of assets to this plan	2010-12-31	$12,872,450
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total income from all sources (including contributions)	2010-12-31	$19,805,580
Total loss/gain on sale of assets	2010-12-31	$0
Total of all expenses incurred	2010-12-31	$312,988
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$312,267
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$16,563,932
Value of total assets at end of year	2010-12-31	$32,365,042
Value of total assets at beginning of year	2010-12-31	$0
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$721
Total interest from all sources	2010-12-31	$1,272
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$632,816
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2010-12-31	$632,816
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$500,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$3,171,080
Participant contributions at end of year	2010-12-31	$47,298
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$8,927,421
Value of other receiveables (less allowance for doubtful accounts) at end of year	2010-12-31	$12
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2010-12-31	$0
Assets. Loans (other than to participants) at end of year	2010-12-31	$47,298
Assets. Loans (other than to participants) at beginning of year	2010-12-31	$0
Administrative expenses (other) incurred	2010-12-31	$721
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$19,492,592
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$32,365,042
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$0
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$31,357,585
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$0
Value of interest in pooled separate accounts at end of year	2010-12-31	$960,127
Value of interest in pooled separate accounts at beginning of year	2010-12-31	$0
Interest on participant loans	2010-12-31	$1,272
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2010-12-31	$20
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2010-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$2,581,439
Net investment gain/loss from pooled separate accounts	2010-12-31	$26,121
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$4,465,431
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$312,267
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2010-12-31	No
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	GRANT THORNTON LLP
Accountancy firm EIN	2010-12-31	131656692

Form 5500 Responses for THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN

2022: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Plan funding arrangement – Insurance	Yes
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement – Insurance	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Plan funding arrangement – Insurance	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement – Insurance	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Plan funding arrangement – Insurance	Yes
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement – Insurance	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Plan funding arrangement – Insurance	Yes
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement – Insurance	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Plan funding arrangement – Insurance	Yes
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement – Insurance	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	Yes
2012-01-01	Plan funding arrangement – Insurance	Yes
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement – Insurance	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: THE UNITED STATES PHARMACOPEIAL CONVENTION 401(K) SAVINGS PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	Yes
2011-01-01	Plan funding arrangement – Insurance	Yes
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement – Insurance	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 70688 )

Policy contract number

TT080384

Policy instance

Insurance contract or identification number	TT080384
Number of Individuals Covered	1110
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 70688 )

Policy contract number

TT080384

Policy instance

Insurance contract or identification number	TT080384
Number of Individuals Covered	1061
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 70688 )

Policy contract number

TT080384

Policy instance

Insurance contract or identification number	TT080384
Number of Individuals Covered	1053
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 70688 )

Policy contract number

TT080384

Policy instance

Insurance contract or identification number	TT080384
Number of Individuals Covered	1056
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

TRANSAMERICA FINANCIAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 70688 )

Policy contract number

TT080384

Policy instance

Insurance contract or identification number	TT080384
Number of Individuals Covered	946
Insurance policy start date	2017-01-01
Insurance policy end date	2017-12-31
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	THE UNITED STATES PHARMACOPEIAL CONVENTION
Employer identification number (EIN):	131656692
NAIC Classification:	611000